Acute lymphoblastic leukaemia trials in United States

In United States 232 Also abroad 564

232 trials · From ClinicalTrials.gov, checked 12 November 2026. Ask the study team whether a trial fits you.

Phase 1Taking people
Pilot Imaging Study of Leukemia
Where
Atlanta, Oklahoma City, Washington D.C.
Age
4 years to 80 years
People
60
Run by
University of Oklahoma
See details and how to joinNCT03633955
No phaseTaking people
Behavioral Parenting Skills as a Novel Target for Improving Pediatric Medication Adherence: Study 3
Where
Buffalo
Age
3 years to 9 years
People
100
Run by
Roswell Park Cancer Institute
See details and how to joinNCT06074666
Phase 1/2Taking people
The OPAL Study: AVM0703 for Treatment of Lymphoid Malignancies
Where
Canton, Chicago, Dallas, Duarte, Los Angeles, Louisville, Memphis, Omaha, Weeki Wachee, Whittier
Age
12 years to 95 years
People
144
Run by
AVM Biotechnology Inc
See details and how to joinNCT04329728
Phase 1/2Taking people
Phase 1/2: CD45RA Depleted Stem Cell Addback to Prevent Viral or Fungal Infections Post TCRab/CD19 Depleted HSCT
Where
Philadelphia
Age
1 month to 25 years
People
100
Run by
Children's Hospital of Philadelphia
See details and how to joinNCT06839456
No phaseTaking people
Massage Impact on Sleep in Pediatric Oncology
Where
Philadelphia, Washington D.C.
Age
12 years to 21 years
People
70
Run by
Children's Hospital of Philadelphia
See details and how to joinNCT06892158
Phase 2Taking people
Study of Mogamulizumab With DA-EPOCH or CHOEP in Patients With Aggressive T-cell Lymphoma
Where
New Haven, New York
Age
18 years and over
People
22
Run by
Yale University
See details and how to joinNCT05996185
No phaseTaking people
The Prospective Collection, Storage and Reporting of Data on Patients Undergoing Hematopoietic Stem Cell Transplantation Utilizing a Standard Preparative Regimen
Where
Winston-Salem
Age
18 years to 120 years
People
2,000
Run by
Wake Forest University Health Sciences
See details and how to joinNCT01890486
No phaseTaking people
The Effects of Exercise on Immune Phenotype of Indolent Non-Hodgkin Lymphoma and Chronic Lymphocytic Leukemia Patients
Where
Rochester, Scottsdale
Age
18 years to 80 years
People
70
Run by
Mayo Clinic
See details and how to joinNCT05876923
No phaseTaking people
Backtracking Leukemia-Typical Somatic Mutations in Cord Blood
Where
Minneapolis
Age
Up to 25 years
People
300
Run by
Children's Oncology Group
See details and how to joinNCT05014165
No phaseTaking people
Multiphase Optimization Strategy (MOST) for Treating Pediatric Post-traumatic Stress Disorder (PTSD)
Where
Rochester
Age
8 years to 17 years
People
200
Run by
University of Rochester
See details and how to joinNCT06956781
Phase 2Taking people
MT2021-08T Cell Receptor Alpha/Beta Depletion PBSC Transplantation for Heme Malignancies
Where
Minneapolis
Age
Up to 60 years
People
70
Run by
Masonic Cancer Center, University of Minnesota
See details and how to joinNCT05735717
No phaseTaking people
Standard-of-Care Reduced-Intensity Conditioning (RIC) With 200 Versus 400 cGy of Total Body Irradiation (TBI) in Patients With Acute Leukemia Undergoing First Allogeneic Blood or Marrow Transplantation (BMT)
Where
Baltimore
People
160
Run by
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
See details and how to joinNCT06803745
No phaseNot yet taking people in United States
Evaluation of Prolonged Asparaginase Activity Levels After Calaspargase Pegol Administration
Where
Rochester
Age
Up to 21 years
People
20
Run by
Mayo Clinic
See details and how to joinNCT07221656
Phase 1/2Taking people
Co-administration of CART22-65s and huCART19 for B-ALL
Where
Philadelphia
Age
Up to 29 years
People
93
Run by
Stephan Grupp MD PhD
See details and how to joinNCT05674175
Phase 1Taking people
Asciminib Maintenance Therapy Following alloHCT or CAR T to Prevent Relapse in Adults With Ph+ALL
Where
Tampa
Age
18 years and over
People
36
Run by
H. Lee Moffitt Cancer Center and Research Institute
See details and how to joinNCT07250087
Phase 1Taking people
Expanded/Activated Gamma Delta T-cell Infusion Following Hematopoietic Stem Cell Transplantation and Post-transplant Cyclophosphamide
Where
Columbus, Westwood
Age
18 years to 65 years
People
38
Run by
University of Kansas Medical Center
See details and how to joinNCT03533816
Phase 2Taking people
CAR T CELL Therapy for Pediatric, Adolescent and Young Adult Patients With CD19-Positive Leukemia
Where
Memphis
Age
Up to 21 years
People
25
Run by
St. Jude Children's Research Hospital
See details and how to joinNCT06847269
Phase 1/2Taking people
A Phase 1/2 Study of Enzomenib (DSP-5336) in Patients With Acute Leukemia (Horizen-1)
Where
Baltimore, Boston, Buffalo, Chapel Hill, Charleston, Charlottesville, Chicago, Columbus, Denver, Durham, Eugene, Fairfax, Houston, Miami, Morristown, Nashville, New Brunswick, Newport Beach, New York, Norfolk, Palo Alto, Philadelphia, Pittsburgh, Salt Lake City, Tampa, Washington D.C., Winston-Salem
Age
12 years and over
People
606 worldwide
Run by
Sumitomo Pharma America, Inc.
See details and how to joinNCT04988555
Phase 1/2Taking people
A Study to Investigate LP-118, Ponatinib, Vincristine and Dexamethasone in Relapsed/Refractory Acute Lymphoblastic Leukemia (ALL) or Lymphoblastic Lymphoma (LBL)
Where
Chicago, Rochester
Age
18 years and over
People
15
Run by
University of Chicago
See details and how to joinNCT06207123
Phase 2Taking people
A Platform Protocol to Investigate Post-Transplant Cyclophosphamide-Based Graft-Versus-Host Disease Prophylaxis in Patients With Hematologic Malignancies Undergoing Mismatched Unrelated Donor Peripheral Blood Stem Cell Transplantation
Where
Birmingham, Boston, Chapel Hill, Charlottesville, Detroit, Duarte, Houston, Miami, New York, Palo Alto, Portland, Seattle, Westwood
Age
18 years to 66 years
People
358
Run by
Center for International Blood and Marrow Transplant Research
See details and how to joinNCT06859424
Phase 1Taking people
Venetoclax Basket Trial for High Risk Hematologic Malignancies
Where
Atlanta, Aurora, Boston, Chicago, San Francisco
Age
1 year to 40 years
People
30
Run by
Andrew E. Place, MD
See details and how to joinNCT05292664
Phase 1Taking people
UCD19 CAR T Therapy in Adults With B-ALL and MRD Positivity in CR1
Where
Aurora
Age
18 years and over
People
29
Run by
University of Colorado, Denver
See details and how to joinNCT05535855
No phaseTaking people
Pediatric Normative Markerless Movement Analysis
Where
Puyallup
Age
3 years to 25 years
People
40
Run by
MultiCare Health System Research Institute
See details and how to joinNCT06249880
Phase 2Taking people
Orphan Indications for CD19 Redirected Autologous T Cells
Where
Philadelphia
Age
0 years to 29 years
People
133
Run by
Stephan Grupp MD PhD
See details and how to joinNCT04276870
Phase 1Taking people
CalPeg for Newly Diagnosed Acute Lymphoblastic Leukemia (ALL)
Where
Tampa
Age
18 years to 50 years
People
7
Run by
H. Lee Moffitt Cancer Center and Research Institute
See details and how to joinNCT05581030